Abstract
Vitiligo is an acquired cutaneous achromia characterized by depigmented macules of various shapes and sizes occurring irrespective of age, sex, and race. Vitiligo in children differs from that in adults by showing a higher incidence in females, segmental vitiligo being more common and less frequently associated with other systemic autoimmune and endocrine disorders. Childhood vitiligo deserves special attention not only because of its frequent occurrence but also being a tough challenge as regards to treatment is concerned.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Al-Otaibi SR, Zadeh VB, Al-Abdulrazzaq AH, et al. Using a 308-nm excimer laser to treat vitiligo in Asians. Acta Dermatovenerol Alp Panonica Adriat. 2009;18:13–9.
Antoniou C, Miniati A, Lagogianni E, et al. Childhood- and later-onset vitiligo have diverse epidemiologic and clinical characteristics. J Am Acad Dermatol. 2012;66:954–8.
Bickers RD, Athar M. Oxidative stress in the pathogenesis of skin disease. J Invest Dermatol. 2006;126:2565–75.
Birol A, Kisa U, Kurtipek GS, et al. Increased tumor necrosis factor alpha (TNF-alpha) and interleukin 1 alpha (IL1-alpha) levels in the lesional skin of patients with nonsegmental vitiligo. Int J Dermatol. 2006;45:992–3.
Brazzelli V, Prestinari F, Castello M, et al. Useful treatment of vitiligo in 10 children with UVB narrowband (311 nm). Pediatr Dermatol. 2005;22:257–61.
Cho S, Kang HC, Hahm JH. Characteristics of vitiligo in Korean children. Pediatr Dermatol. 2000;17:189–93.
Cho S, Zheng Z, Park YK, Roh MR. The 308 nm excimer laser: a promising device for the treatment of childhood vitiligo. Photodermatol Photoimmunol Photomed. 2011;27:24–9.
Dell’anna ML, Picardo M. A review and a new hypothesis for non-immuno-logical pathogenetic mechanisms in vitiligo. Pigment Cell Res. 2006;19:406–11.
Gargoom AM, Duweb GA, Elzorghany AH, et al. Calcipotriol in the treatment of childhood vitiligo. Int J Clin Pharmacol Res. 2004;24:11–4.
Grimes PE, Soriano T, Dytoc MT. Topical tacrolimus for repigmentation of vitiligo. J Am Acad Dermatol. 2002;47:789–91.
Gupta S, Kumar B. Epidermal grafting for vitiligo in adolescents. Pediatr Dermatol. 2002;19:159–62.
Gupta S, Kumar B. Epidermal grafting in vitiligo: influence of age, site of lesions, and type of disease on outcome. J Am Acad Dermatol. 2003;49:99–104.
Halder RM. Childhood vitiligo. Clin Dermatol. 1997;15:899–906.
Hui-Lan Y, Xiao-Yan H, Jian-Yong F, Zong- Rong L. Combination of 308 nm excimer laser with topical pimecrolimus for the treatment of childhood vitiligo. Paediatr Dermatol. 2009;26:354–6.
Jeong YM, Choi YG, Kim DS, et al. Cytoprotective effect of green tea extract and quercetin against hydrogen peroxide-induced oxidative stress. Arch Pharm Res. 2005;28:1251–6.
Kanwar AJ, Kumaran MS. Childhood vitiligo: treatment paradigms. Indian J Dermatol. 2012;57:466–74.
Kanwar AJ, Dogra S, Parsad D. Topical tacrolimus for treatment of childhood vitiligo in Asians. Clin Exp Dermatol. 2004;29:589–92.
Kanwar AJ, Dogra S. Narrow-band UVB for the treatment of generalized vitiligo in children. Clin Exp Dermatol. 2005;30:332–6.
Koranne RV, Sachdeva KG. Vitiligo. Int J Dermatol. 1988;27:676–80.
Kose O, Arca E, Kurumlu Z. Mometasone cream versus pimecrolimus cream for the treatment of childhood localized vitiligo. J Dermatolog Treat. 2010;21:133–9.
Kumaran MS, Kaur I, Kumar B. Effect of topical calcipotriol, betamethasone dipropionate and their combination in the treatment of localized vitiligo. J Eur Acad Dermatol Venereol. 2006;20:269–73.
Lepe V, Moncada B, Castanedo-Cazares JP, et al. A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for treatment of childhood vitiligo. Arch Dermatol. 2003;139:582–5.
Le Poole IC, Luiten RM. Autoimmune etiology of generalized vitiligo. Curr Dir Autoimmun. 2008;10:227–43.
Majid I, Imran S. Relapse after methylprednisolone oral minipulse therapy in childhood vitiligo: a 12-month follow-up study. Indian J Dermatol. 2013;58:113–6.
Marshal K. Therapeutic applications of whey protein. Altern Med Rev. 2004;2:136–56.
Meyskens Jr FL, Farmer P, Fruehauf JP. Redox regulation in human melanocytes and melanoma. Pigment Cell Res. 2001;14:148–54.
Morelli J. Vitiligo: is there a treatment that works? Pediatr Dermatol. 2001;17:81.
Mulekar SV, Al Aisa A, Delvi MB, et al. Childhood vitiligo: a long term study of localized vitiligo treated by non cultured cellular grafting. Paedtr Dermatol. 2010;27:132–6.
Namazi MR, Chee Leok G. Vitiligo and diet: a theoretical molecular approach with practical implications. Indian J Dermatol Venereol Leprol. 2009;75:116–8.
Njoo MD, Bos JD, Westerhof W. Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy. J Am Acad Dermatol. 2000;42:245–53.
Nordlund JJ, Boissy RE, Hearing VJ, King RA, Oetting WS, Ortonne J-P, editors. The pigmentary system. Malden: Blackwell; 2006. p. 551–98.
Obayashi K, Kurihara K, Okano Y, et al. L-Ergothioneine scavenges superoxide and singlet oxygen and suppresses TNF-alpha and MMP-1 expression in UV-irradiated human dermal fibroblasts. J Cosmet Sci. 2005;56:17–27.
Ongenae K, Van Geel N, Naeyeert JM. Evidence for an autoimmune pathogenesis of vitiligo. Pigment Cell Res. 2003;16:90–100.
Pajvani U, Ahmad N, Wiley A, et al. The relationship between family medical history and childhood vitiligo. J Am Acad Dermatol. 2006;55:238–44.
Parsad D, Saini R, Nagpal R. Calcipotriol in vitiligo: preliminary study. Pediatr Dermatol. 1999;16:317–20.
Pasricha JS, Khaitan BK. Oral mini-pulse therapy with betamethasone in vitiligo patients having extensive or fast spreading disease. Int J Dermatol. 1993;32:753–7.
Sahni K, Parsad D, Kanwar AJ. Noncultured epidermal suspension transplantation for the treatment of stable vitiligo in children and adolescents. Clin Exp Dermatol. 2011;36:607–12.
Sarma N, Singh AK. Topical calcipotriol in childhood vitiligo: an Indian experience. Int J Dermatol. 2004;43:856–9.
Silverberg NB, Lin P, Travis L, et al. Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases. J Am Acad Dermatol. 2004;51:760–6.
Spritz RA. The genetics of generalized vitiligo. Curr Opin Autoimmun. 2008;10:244–57.
Sturm RA. Human pigmentation genes and their response to solar UV radiation. Mutat Res. 1998;422:69–76.
Tamesis MEB, Morelli MD. Vitiligo treatment in childhood: a state of the art review. Pediatr Dermatol. 2010;27:437–45.
Travis LB, Silverberg NB. Calcipotriene and corticosteroid combination therapy for vitiligo. Pediatr Dermatol. 2004;21:495–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Sarkar, R., Bansal, S. (2016). Childhood Vitiligo. In: Oranje, A., Al-Mutairi, N., Shwayder, T. (eds) Practical Pediatric Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-319-32159-2_14
Download citation
DOI: https://doi.org/10.1007/978-3-319-32159-2_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-32157-8
Online ISBN: 978-3-319-32159-2
eBook Packages: MedicineMedicine (R0)